Claims for Patent: 7,089,121

Summary for Patent: 7,089,121

Title:	Methods for monitoring the expression of alternatively spliced genes
Abstract:	Methods, probe arrays and computer software products are provided for determining the arrangement of sequence elements. In one embodiment, methods for making and using exon chips are provided. The exon chips may be used to identify and quantify splice variants.
Inventor(s):	Wang; Hui (San Mateo, CA)
Assignee:	Affymetrix, Inc. (Santa Clara, CA)
Application Number:	10/448,566
Patent Claims:	1. A computer-implemented method for analyzing the expression of splice variants comprising: a. Selecting a plurality of transcripts of a gene from sequence databases; b. Aligning a sequence of said transcripts to a corresponding genomic sequence; c. Identifying gene features from at least one part of said transcripts aligned with the corresponding genomic sequence; d. Selecting oligonucleotides probes targeting said gene features; e. Hybridizing a target nucleic acid to an array of said oligonucleotide probes; f. Obtaining a plurality of probe intensities, wherein the probe intensities indicates the level of the hybridization of nucleic acid probes with various gene structures wherein the structures identify each splice variant; g. Analyzing the probe intensities across multiple experiments with a model-based algorithm wherein the gene structures are constraints; and h. Estimating the relative concentration of the splice variants with model parameters wherein the model parameters are obtained through a maximum likelihood estimation process. 2. The method of claim 1 wherein the oligonucleotide probes are immobilized on a substrate. 3. The method of claim 1 wherein the gene features include a plurality of exons. 4. The method of claim 1 wherein the gene features include at least one partial exon. 5. The method of claim 1 wherein the gene features include at least one intron. 6. The method of claim 1 wherein the gene features include at least one exon--exon junction, one exon-intron junction and one intron-exon junction. 7. The method of claim 1 wherein a combination of the gene features defines a splice variant.

Details for Patent 7,089,121

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2039-02-26